Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2003

View Archived Issues

New GSK-3 inhibitors in early development at Novo Nordisk

Vertex claims novel inhibitors of GSK-3, Aurora-2 and CDK2

Novel alpha4 integrin antagonists discovered at Ajinomoto

Merck KGaA patents new insulin secretagogues

Novel CRF1-selective ligands designed by Salk Institute scientists

Modulators of peroxisome proliferator-activated receptors in Novo Nordisk pipeline

AstraZeneca describes new NOS inhibitors for arthritis and pain

New antiangiogenic peptides with utility in cancer claimed by Abbott

Somatostatin analogues and their use in cancer diagnosis and treatment reported by Mallinckrodt

Pharmagenesis and Pierre Fabre sign license agreement for PG-490-88Na

MicroIslet and Scripps enter islet cell transplantation collaboration

FDA advisory committee recommends additional analyses of Vitrase data

Protein Design Labs licenses SMART M195 antibody to Actinium

Anidulafungin as effective as fluconazole in esophageal candidiasis in phase III trial

Human Genome Sciences develops ABthrax

Helicide approved in Canada for H. pylori eradication

Preparations for late-stage phase II trial of Product R for AIDS

Tanabe Seiyaku to commercialize Actiq in Japan

Levitra introduced in Germany for ED

Immunological and virological effects induced by enfuvirtide in HIV-infected patients

Mirtazapine safe and effective in posttraumatic stress disorder

HOPE data on the costs of ramipril therapy in cardiovascular diseases

DTI-015 affords 40% cure rate and over 400% increase in life span in rats with brain cancer

Acetylcysteine associated with lower incidence of cardiovascular events in end-stage renal failure

Calcimimetic reduces PTH levels in hyperparathyroidism secondary to hemodialysis

Novartis to acquire Pfizer incontinence drug

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026